Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial
Rockstroh, Juergen K, Plonski, Frank, Bansal, Meena, Fätkenheuer, Gerd, Small, Catherine B, Asmuth, David M, Pialoux, Gilles, Zhang-Roper, Rebecca, Wang, Ronnie, Pineda, Juan A, Heera, JayvantYear:
2016
Language:
english
Journal:
Antiviral therapy
DOI:
10.3851/IMP3116
File:
PDF, 935 KB
english, 2016